Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ballen

Showing results (11-20 of 164) with videos related to

Pageof 17
Sort By:
British Journal of Haematology|January 15, 2016
Cord blood transplant for acute myeloid leukaemiaKaren K Ballen, Hillard Lazarus
Best Practice & Research. Clinical Haematology|September 15, 2010
The role of HLA in umbilical cord blood transplantationMeghan Delaney, Karen K Ballen
Current Opinion in Oncology|November 25, 1997
Adoptive immunotherapyK Ballen, F M Stewart
Bone Marrow Transplantation|February 5, 2008
SCT in Jehovah's Witnesses: the bloodless transplantJ M Sloan, K Ballen
Journal of Intensive Care Medicine|June 12, 2013
Umbilical cord blood transplantation: review of factors affecting the hospitalized patientMeghan Delaney, Karen K Ballen
Best Practice & Research. Clinical Haematology|November 30, 2019
What have we learned from transplanting older patients?Indumathy Varadarajan, Karen K Ballen
Acta Haematologica|June 23, 2020
Allogeneic Transplantation for Myelofibrosis with Novel Graft-versus-Host Disease ProphylaxisLeonid Volodin, Karen K Ballen
The New England Journal of Medicine|January 22, 2005
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 2-2005. A 39-year-old woman with headache, stiff neck, and photophobiaKaren K Ballen, Robert P Hasserjian
British Journal of Haematology|November 7, 2019
Treatment of acute leukaemia in adult Jehovah's WitnessesFiras El Chaer, Karen K Ballen
Bone Marrow Transplantation|July 28, 2022
Measurable residual disease for secondary acute myeloid leukemia prior to allogeneic hematopoietic cell transplantation: does it make a difference?Firas El Chaer, Karen K Ballen
Pageof 17

Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
British Journal of Haematology|January 15, 2016
Cord blood transplant for acute myeloid leukaemiaKaren K Ballen, Hillard Lazarus
Best Practice & Research. Clinical Haematology|September 15, 2010
The role of HLA in umbilical cord blood transplantationMeghan Delaney, Karen K Ballen
Current Opinion in Oncology|November 25, 1997
Adoptive immunotherapyK Ballen, F M Stewart
Bone Marrow Transplantation|February 5, 2008
SCT in Jehovah's Witnesses: the bloodless transplantJ M Sloan, K Ballen
Journal of Intensive Care Medicine|June 12, 2013
Umbilical cord blood transplantation: review of factors affecting the hospitalized patientMeghan Delaney, Karen K Ballen
Best Practice & Research. Clinical Haematology|November 30, 2019
What have we learned from transplanting older patients?Indumathy Varadarajan, Karen K Ballen
Acta Haematologica|June 23, 2020
Allogeneic Transplantation for Myelofibrosis with Novel Graft-versus-Host Disease ProphylaxisLeonid Volodin, Karen K Ballen
The New England Journal of Medicine|January 22, 2005
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 2-2005. A 39-year-old woman with headache, stiff neck, and photophobiaKaren K Ballen, Robert P Hasserjian
British Journal of Haematology|November 7, 2019
Treatment of acute leukaemia in adult Jehovah's WitnessesFiras El Chaer, Karen K Ballen
Bone Marrow Transplantation|July 28, 2022
Measurable residual disease for secondary acute myeloid leukemia prior to allogeneic hematopoietic cell transplantation: does it make a difference?Firas El Chaer, Karen K Ballen
Pageof 17